Characterization of trimethylamine metabolic pathways using pseudo-targeted metabolomics
- 4 February 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 258, 116737
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Support Program of Jiangsu Province (BE2023772)
- National Natural Science Foundation of China (82074089, 82204591)
This publication has 34 references indexed in Scilit:
- Orthogonal label and label-free dual pretreatment for targeted profiling of neurotransmitters in enteric nervous systemAnalytica Chimica Acta, 2020
- Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty AcidsCell Systems, 2020
- Ammonium fluoride-induced stabilization for anion attachment mass spectrometry: Facilitating the pseudotargeted profiling of bile acids submetabolomeAnalytica Chimica Acta, 2019
- A sensitive, high-throughput LC-MS/MS method for measuring catecholamines in low volume serumAnalytica Chimica Acta, 2018
- Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline ConsumptionCell Host & Microbe, 2017
- Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular eventsKidney International, 2016
- Signaling in Host-Associated Microbial CommunitiesCell, 2016
- Pseudotargeted Metabolomics Method and Its Application in Serum Biomarker Discovery for Hepatocellular Carcinoma Based on Ultra High-Performance Liquid Chromatography/Triple Quadrupole Mass SpectrometryAnalytical Chemistry, 2013
- Carnitine and AcylcarnitinesClinical Pharmacokinetics, 2012
- Metabolomics Reveals that Hepatic Stearoyl-CoA Desaturase 1 Downregulation Exacerbates Inflammation and Acute ColitisCell Metabolism, 2008